444 search results for “drug” in the Student website
-
Leiden ‘super antibiotic’ keeps dangerous gut bacterium under control with a low dose
The antibiotic EVG7, developed in Leiden, has proven capable of fighting the dangerous gut bacterium C. difficile with only a minimal dose. What’s more, the bacterium is far less likely to return, a major issue with existing antibiotics. The research was published in Nature Communications.
-
Bas ter BraakFaculty of Science
-
Marije NiemeijerFaculty of Science
-
Thomas HankemeierFaculty of Science
-
Joost BatenburgFaculty of Science
-
Bola KhalilFaculty of Science
-
Willem JespersFaculty of Science
-
Brandon BongersFaculty of Science
-
Nasi LiuFaculty of Science
-
Rosan KuinFaculty of Science
-
Marjolijn LugthartFaculty of Science
-
Dario BijkerFaculty of Science
-
Daan JiskootFaculty of Science
-
Marc BoefFaculty of Science
-
Linde SchoenmakerFaculty of Science
-
Martijn Moné
Faculty of Science
-
Agreements
Read here about the various agreements in place at Leiden University for student and study associations and other student organisations.
-
Olivier BéquignonFaculty of Science
-
Mick van SchaickFaculty of Science
-
Britt DuijndamFaculty of Science
-
Klara BeslmüllerFaculty of Science
-
Ine TijdensFaculty of Science
-
Hanneke LeegwaterFaculty of Science
-
Marina Gorostiola GonzálezFaculty of Science
-
Xuesong WangFaculty of Science
-
Kirsten VeltmanFaculty of Science
-
Jurjun van der VeldeFaculty of Science
-
How Oncode-PACT is bringing new cancer medicines closer with 325 million in Growth Fund money
How can you ensure that more experimental drugs reach the finish line? At the moment, only one in twenty cancer drugs that are tested on humans makes it to the market. This is an enormous loss for patients and society. With a grant from the National Growth Fund, Oncode-PACT aims to efficiently select…
-
Seeking new concepts to treat diseases
Scientific Director of the Leiden Academic Centre for Drug Research (LACDR) Hubertus Irth: ‘We test substances and look for new concepts for treating disease.’
-
‘Never stop trying’: Barz sees his polymers enter clinical trials
A new class of polymers has been used in patients for the first time. The compound is the first new drug solubilising agent in decades. Introduced in 2014 by chemist Matthias Barz from Leiden University, it offers a unique alternative to current options.
-
Ian Shen
Faculty of Science
-
A smarter way to search for antibiotics
Bacteria carry countless hidden treasures in their DNA: fragments that could hold the key to new medicines. But how do you pick out the most promising ones from millions of options? ‘Look at the switches that turn genes on and off,’ says molecular biologist Gilles van Wezel.
-
Remco van den BroekFaculty of Science
-
David Figueiredo VidalFaculty of Science
-
Cristina Serra I Melendez
Faculty of Science
-
Lucina-May NollenFaculty of Science
-
Building a greener future at Leiden University in 2025
From a vegan community kitchen to a green framework for drug development: sustainability became more visible in everyday campus life at Leiden University in 2025.
-
Madouc Bergers made her own enzyme inhibitors for her bachelor’s thesis
For her bachelor’s thesis, Molecular Science and Technology student Madouc Bergers synthesized her own molecule that can inhibit the breakdown of sugars. Although most students do not even manage to make one building block, Madouc made three. Partly because of this, she has been nominated for the Science…
-
Sylvia Le DévédecFaculty of Science
-
Jos Jonkers
Faculty of Science
-
Anita LiaoFaculty of Science
-
Tessa HagensFaculty of Science
-
Steffen BrünleFaculty of Science
-
During the next pandemic, this mathematical model will speed up the search for treatment
Do you recall all those drugs that were hastily proposed as potential treatments for COVID-19? In the event of a future pandemic, the goal is to offer an effective treatment more quickly and efficiently. To achieve this, a team led by Coen van Hasselt is developing a platform that can speed up the process…
-
Medical Delta AI for Computational Life Sciences
The fact that scientists are increasingly better able to access molecular cell and tissue data also brings with it a new challenge: how can scientists find the information they need for research among the vast amount of data available?
-
Koos Burggraaf
Faculty of Science
-
Cecile HerbermannFaculty of Science
-
Nina SchultenFaculty of Science
-
Ferdinand TeichertFaculty of Science
-
Zoran GavricFaculty of Science